Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0149514 (
bronchitis
)
6,902
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Human T-lymphotropic virus types I and II (HTLV-I and -II) cause myelopathy; HTLV-I, but not HTLV-II, causes adult T-cell leukemia. Whether HTLV-II is associated with other diseases is unknown. Using survival analysis, we studied medical history data from a prospective cohort of HTLV-I- and HTLV-II-infected and -uninfected blood donors, all HIV seronegative. A total of 152 HTLV-I, 387 HTLV-II, and 799 uninfected donors were enrolled and followed for a median of 4.4, 4.3, and 4.4 years, respectively. HTLV-II participants had significantly increased incidences of
acute bronchitis
(incidence ratio [IR] = 1.68), bladder or
kidney infection
(IR = 1.55), arthritis (IR = 2.66), and asthma (IR = 3.28), and a borderline increase in pneumonia (IR = 1.82, 95% confidence interval [CI] 0.98 to 3.38). HTLV-I participants had significantly increased incidences of bladder or
kidney infection
(IR = 1.82), and arthritis (IR = 2.84). We conclude that HTLV-II infection may inhibit immunologic responses to respiratory infections and that both HTLV-I and -II may induce inflammatory or autoimmune reactions.
...
PMID:Respiratory and urinary tract infections, arthritis, and asthma associated with HTLV-I and HTLV-II infection. 1507 5
Intravenous and aerosol challenge experiments were conducted to evaluate tracheal and renal cross-protection in chickens immunized either with infectious
bronchitis
virus vaccine strains or with nephropathogenic infectious
bronchitis
virus (NIBV)-isolates. Intravenous challenge was carried out with four Belgian NIBV-isolates and with the Italian NIBV-strain AZ23.74. Virus titrations of tracheas collected at different times after aerosol challenge with the Belgian reference NIBV-strain B1648 demonstrated that only chickens immunized with the serologically closely related Belgian NIBV-field isolates showed strong trachea protection. The three vaccine strains H120, H52 and D274 and the heterologous NIBV-strain AZ23.74 did not induce protection of the respiratory tract against B1648. However, immunization with the latter strains shortened the period of replication of the challenge virus in the trachea. All chickens immunized with NIBV were strongly protected against nephritis after challenge with a homologous or heterologous NIBV-isolate. Vaccination with H52 gave partial kidney protection against NIBV challenge. Vaccination with H120 or D274 did not reduce
kidney infection
after NIBV challenge, as demonstrated by the incidence of mortality and kidney-immunofluorescence. Protection of the kidney was similar whether the challenge was performed intravenously or by aerosol. The results of both challenge experiments show that the development of a vaccine strain based on the Belgian NIBV-serotype is indicated to control NIBV in Belgian broiler flocks.
...
PMID:Challenge experiments to evaluate cross-protection induced at the trachea and kidney level by vaccine strains and Belgian nephropathogenic isolates of avian infectious bronchitis virus. 1867 Oct 42
White Leghorn chicks without and with maternally derived antibodies (MDA) to infectious
bronchitis
virus (IBV) and broiler chicks with MDA were vaccinated at 1 day of age either with H120 vaccine, combined H120 and D274 vaccines or with a non-commercial attenuated strain derived from the virulent Belgian nephropathogenic IBV strain, B1648. Protection following challenge with virulent B1648 was assessed 4 weeks later by virus isolation from the trachea, antigen detection in the kidney by immunofluorescence and mortality rates. Vaccination with either homologous or heterologous vaccines reduced the duration of virus replication in the trachea of all groups compared to unvaccinated controls. Homologous vaccination reduced the incidence of virus replication in the kidney. Heterologous vaccination (H120 to D274) did not reduce
kidney infection
in the MDA + groups; however, partial kidney-protection was found in the MDA - group. There was no correlation between serum antibody titres measured by ELISA and the degree of kidney protection.
...
PMID:Vaccination of chickens against a Belgian nephropathogenic strain of infectious bronchitis virus B1648 using attenuated homologous and heterologous strains. 1867 Nov 30